PharmaCann Inc.

About PharmaCann Inc.

PharmaCann is one of the largest vertically integrated cannabis companies in the country, focused on improving people's lives through cannabis since 2014. They provide safe, reliable, and top-quality cannabis products while shaping a wellness-focused industry by investing in people, practices, and infrastructure. Their mission includes advancing access to cannabis through effective, affordable, and trusted products and services, built on trust and creating a positive impact in the world.

Products & Services

Market-Leading Products:A house of brands designed for people seeking a simpler way to find and experience the joy of cannabis.

Trusted Dispensaries:Retail dispensaries under the brands LivWell and Verilife, offering robust menus for medical patients and recreational shoppers across multiple states.

Specialties

Vertically Integrated Cannabis Solutions Cannabis Cultivation and Processing Retail Dispensary Operations Wellness-Focused Cannabis Products

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Debt T: - FT: Debt	A: 7600000 MR: - FA: 7.6 million FAN: 7600000	D: 2023-08-07 FD: 2023-08-07	1 investors

Debt Latest

2023-08-07

$7.6M

1 investor (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

No team data available

Team information is not yet available for this company

Recent News

PharmaCann Inc. Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised